Results 101 to 110 of about 239,516 (296)

The value of DALY life: problems with ethics and validity of disability adjusted life years

Leprosy Review, 1999
Disability adjusted life years (DALYs) have been launched by the World Bank and backed by the World Health Organisation as a measure of the global burden of disease. 1 2 The aim is ambitious: “The burden of disease has yet to entirely replace traditional approaches to the assessment of health needs as an influence on political decision making.”3 Just ...
T, Arnesen, E, Nord
openaire   +4 more sources

Disability-Adjusted Life Years (DALYs), DALYs averted, and cost per DALY averted under different mortality scenarios (base, best and worst) for the community based treatment and prevention programme versus ICDS standard care only.

, 2018
Disability-Adjusted Life Years (DALYs), DALYs averted, and cost per DALY averted under different mortality scenarios (base, best and worst) for the community based treatment and prevention programme versus ICDS standard care only.
A. Jayaraman (5949617), P. Griffiths (5949632), S. Chanani (5949620), B. Bogin (5949626), S. Goudet (5949614), N. Madise (5949629), D. Osrin (5949623), B. Devleesschauwer (3501476)   +7 more
core   +1 more source

Global, Regional, And National Cancer Incidence, Mortality, Years Of Life Lost, Years Lived With Disability, And Disability-Adjusted Life-Years For 29 Cancer Groups, 1990 To 2016: A Systematic Analysis For The Global Burden Of Disease Study [PDF]

, 2018
Importance: The increasing burden due to cancer and other noncommunicable diseases poses a threat to human development, which has resulted in global political commitments reflected in the Sustainable Development Goals as well as the World Health ...
Additional Authors, Alvis-Guzmán, Nelson, Alvis Guzman, Nelson Rafael   +2 more
core   +1 more source

Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket, J. Lycke, J. Salzer, F. Piehl, K. Fink, N. Lange, J. Mellergård, C. Malmeström, P. Sundström, I. Erngren, A. al‐Grety, E. Freyhult, K. Kultima, J. Burman, A. Svenningsson   +14 more
wiley   +1 more source

Global, regional, and national burden of tobacco-related neurological disorders from 1990 to 2021: Trends and future projections

Tobacco Induced Diseases
Introduction Tobacco use is as a major public health concern around the world, adversely impacting quality of life. Our study aims to analyze the trends in the burden of tobacco-related neurological disorders (ND) at global, regional, and national levels
Chenyang Zhang, Zhihan An, Jixuan Jiang, Jingyi Ge, Wanqiong Huang, Jialin Pei, Yiyao Liu, Jiayu Yao, Zirui Guo, Xuanxi Liu, Yanhui Cui   +10 more
doaj   +1 more source

Stillbirths: how should its rate be reported, its disability-adjusted-life-years (DALY), and stillbirths adjusted life expectancy

BMC Medical Informatics and Decision Making, 2019
Background A 2016 study standardized the definition of stillbirths. It estimated the rate as a proportion of total births. A 2015 paper addressed the problem of disability-adjusted life-years (DALY) for stillbirths.
Chander Kant
doaj   +1 more source

Comprehensive Assessment of Arterial, Tissue, and Venous Collaterals for Evaluating the Infarct Growth Rate: The Multimodal Collateral Score

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Collaterals are crucial factors that influence the infarct growth rate (IGR). We aimed to determine whether a comprehensive multimodal collateral score (MCS), incorporating collateral assessment at the arterial, tissue, and venous levels, is associated with functional independence and provides incremental prognostic value over ...
Giorgio Busto, Umberto Pensato, Ilaria Casetta, Giorgio U. Marcello, Angelo Barra, Anna Poggesi, Edoardo Carlesi, Sara Mancini, Andrea Ginestroni, Vittorio Miele, Alessandro Padovani, Andrea Morotti, Enrico Fainardi   +12 more
wiley   +1 more source

Movement Disorders in Aicardi–Goutières Syndrome and Response to Immunomodulation

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT This study characterizes movement disorders and treatment responses in seven children with Aicardi–Goutières syndrome (AGS). We retrospectively evaluated motor phenotypes, neuroimaging, and interferon signatures in patients treated with baricitinib or anifrolumab. Spasticity affected all patients, while dystonia was present in 4/7.
Enrique Gonzalez Saez‐Diez, Monica Ferrer Socorro, Kathryn Yang, Nicole Battaglia, Zainab Zaman, Mariko Bennett, Adeline Vanderver, Pui Y. Lee, Lauren A. Henderson, Milena M. Andzelm, Darius Ebrahimi‐Fakhari   +10 more
wiley   +1 more source

Global, regional, and national burdens of pertussis among adults: a systematic analysis of age-specific trends using Global Burden of Diseases 2021 data

Infectious Diseases of Poverty
Background Despite the high coverage of childhood vaccination, pertussis remains a significant global health challenge, with increasing adult cases attributed to waning immunity and enhanced diagnostic capability.
Kangguo Li, Jiadong Wu, Ruixin Zhang, Yulun Xie, Zecheng Zhou, Qi Yin, Qi Chen, Jia Rui, Xuhua Guan, Zeyu Zhao, Tianmu Chen   +10 more
doaj   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source